Paresis - 146 Studies Found
Recruiting |
: Evaluation of Patients With HAM/TSP :
: 1999-11-03 |
Recruiting |
: Raltegravir for HAM/TSP : HTLV-I Infection : 2013-05-21 : Drug: Raltegravir |
Terminated |
: The HAM Infliximab Study : HTLV-I-associated Myelopathy : 2009-01-14 : Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Completed |
: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial : HTLV-I-associated Myelopathy : 2006-01-04 : Drug: Zidovudine/lamivudine |
Completed |
: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis : Tropical Spastic Paraparesis : 2002-05-01 |
Completed |
: Use Of Valproid Acid To Treat Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM) : Paraparesis Spastic Tropical : 2008-05-19 :
|
Not yet recruiting |
: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection :
: 2015-11-16 : Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |
Not yet recruiting |
: Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) : HTLV-I-Associated Myelopathy : 2011-04-25 : Drug: Tamibarotene Oral administration of tamibarotene 2 mg daily over a period of 12 weeks, then 4mg da |
Completed |
: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis : HTLV-I : 2006-06-19 |
Recruiting |
: Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis : HTLV-1 : 2006-07-12 : Drug: Hu MiK-Beta-1 |